2-pyridinyl-3-(4-methylsulfonyl)phenylpyridines:: Selective and orally active cyclooxygenase-2 inhibitors

被引:131
作者
Friesen, RW [1 ]
Brideau, C [1 ]
Chan, CC [1 ]
Charleson, S [1 ]
Deschênes, D [1 ]
Dubé, D [1 ]
Ethier, D [1 ]
Fortin, R [1 ]
Gauthier, JY [1 ]
Girard, Y [1 ]
Gordon, R [1 ]
Greig, GM [1 ]
Riendeau, D [1 ]
Savoie, C [1 ]
Wang, ZY [1 ]
Wong, E [1 ]
Visco, D [1 ]
Xu, LJ [1 ]
Young, RN [1 ]
机构
[1] Merck Frosst Canada Inc, Merck Frosst Ctr Therapeut Res, Pointe Claire, PQ H9R 4P8, Canada
关键词
D O I
10.1016/S0960-894X(98)00499-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel 2-pyridinyl-3-(4-methylsulfonyl)phenylpyridines has been synthesized and evaluated with respect to their ability to inhibit the isozymes of cyclooxygenase, COX-I, and COX-2. Optimum COX-2 activity is observed by introduction of a substituent at C5 of the central pyridine. 5-Chloro-3-(4-methylsulfonyl)phenyl-2-(2-methyl-5-pyridinyl)pyridine 33 was identified as the optimum compound in this series. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2777 / 2782
页数:6
相关论文
共 26 条
[1]   AROMATIC SUBSTITUTION .14. HOMOLYTIC PHENYLATION OF 3- AND 4-PICOLINE . A QUANTITATIVE STUDY OF ISOMER AND TOTAL RATE RATIOS [J].
ABRAMOVITCH, RA ;
SAHA, M .
CANADIAN JOURNAL OF CHEMISTRY-BACK YEAR, 1966, 44 (15) :1765-+
[2]  
[Anonymous], 1979, HDB EXPT PHARM
[3]  
BATT DG, Patent No. 10012
[4]   A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors [J].
Brideau, C ;
Kargman, S ;
Liu, S ;
Dallob, AL ;
Ehrich, EW ;
Rodger, IW ;
Chan, CC .
INFLAMMATION RESEARCH, 1996, 45 (02) :68-74
[5]  
CHAN CC, 1995, J PHARMACOL EXP THER, V274, P1531
[6]  
DUBE D, Patent No. 03484
[7]  
GANS KR, 1990, J PHARMACOL EXP THER, V254, P180
[8]  
Griswold DE, 1996, MED RES REV, V16, P181, DOI 10.1002/(SICI)1098-1128(199603)16:2<181::AID-MED3>3.0.CO
[9]  
2-X
[10]   HUMAN CYCLOOXYGENASE-2 CDNA [J].
HLA, T ;
NEILSON, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7384-7388